These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27787194)

  • 1. Evolution of Mycobacterium tuberculosis: New Insights into Pathogenicity and Drug Resistance.
    Boritsch EC; Brosch R
    Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27787194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis evolutionary pathogenesis and its putative impact on drug development.
    Le Chevalier F; Cascioferro A; Majlessi L; Herrmann JL; Brosch R
    Future Microbiol; 2014; 9(8):969-85. PubMed ID: 25302954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity in the tubercle bacillus: molecular and evolutionary determinants.
    Gordon SV; Bottai D; Simeone R; Stinear TP; Brosch R
    Bioessays; 2009 Apr; 31(4):378-88. PubMed ID: 19274661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of fluoroquinolone resistance in Mycobacterium tuberculosis.
    Zhang YJ; Li XJ; Mi KX
    Yi Chuan; 2016 Oct; 38(10):918-927. PubMed ID: 27806933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of persisters in tuberculosis drug discovery.
    Mandal S; Njikan S; Kumar A; Early JV; Parish T
    Microbiology (Reading); 2019 May; 165(5):492-499. PubMed ID: 30775961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy.
    Trauner A; Liu Q; Via LE; Liu X; Ruan X; Liang L; Shi H; Chen Y; Wang Z; Liang R; Zhang W; Wei W; Gao J; Sun G; Brites D; England K; Zhang G; Gagneux S; Barry CE; Gao Q
    Genome Biol; 2017 Apr; 18(1):71. PubMed ID: 28424085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of virulence in the Mycobacterium tuberculosis complex.
    Orgeur M; Brosch R
    Curr Opin Microbiol; 2018 Feb; 41():68-75. PubMed ID: 29216510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecology and evolution of Mycobacterium tuberculosis.
    Gagneux S
    Nat Rev Microbiol; 2018 Apr; 16(4):202-213. PubMed ID: 29456241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance mechanisms and novel drug targets for tuberculosis therapy.
    Islam MM; Hameed HMA; Mugweru J; Chhotaray C; Wang C; Tan Y; Liu J; Li X; Tan S; Ojima I; Yew WW; Nuermberger E; Lamichhane G; Zhang T
    J Genet Genomics; 2017 Jan; 44(1):21-37. PubMed ID: 28117224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-Genome Analysis of Mycobacterium tuberculosis from Patients with Tuberculous Spondylitis, Russia.
    Chernyaeva E; Rotkevich M; Krasheninnikova K; Yurchenko A; Vyazovaya A; Mokrousov I; Solovieva N; Zhuravlev V; Yablonsky P; O'Brien SJ
    Emerg Infect Dis; 2018 Mar; 24(3):579-583. PubMed ID: 29460750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.
    Sacchettini JC; Rubin EJ; Freundlich JS
    Nat Rev Microbiol; 2008 Jan; 6(1):41-52. PubMed ID: 18079742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite?
    den Hertog AL; Sengstake S; Anthony RM
    Pathog Dis; 2015 Aug; 73(6):ftv037. PubMed ID: 25994506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in Belarus.
    Wollenberg KR; Desjardins CA; Zalutskaya A; Slodovnikova V; Oler AJ; Quiñones M; Abeel T; Chapman SB; Tartakovsky M; Gabrielian A; Hoffner S; Skrahin A; Birren BW; Rosenthal A; Skrahina A; Earl AM
    J Clin Microbiol; 2017 Feb; 55(2):457-469. PubMed ID: 27903602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis.
    McGrath M; Gey van Pittius NC; van Helden PD; Warren RM; Warner DF
    J Antimicrob Chemother; 2014 Feb; 69(2):292-302. PubMed ID: 24072169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tuberculosis: a glimpse of promising drug targets.
    Arora N; Banerjee AK
    Mini Rev Med Chem; 2012 Mar; 12(3):187-201. PubMed ID: 22356190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis.
    Shcherbakov D; Akbergenov R; Matt T; Sander P; Andersson DI; Böttger EC
    Mol Microbiol; 2010 Aug; 77(4):830-40. PubMed ID: 20545852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming the tuberculosis drug pipeline: new antimycobacterial targets and agents.
    Evans JC; Mizrahi V
    Curr Opin Microbiol; 2018 Oct; 45():39-46. PubMed ID: 29482115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress on mechanism of ethambutol resistance in Mycobacterium Tuberculosis.
    Wang T; Jiao WW; Shen AD
    Yi Chuan; 2016 Oct; 38(10):910-917. PubMed ID: 27806932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.